Edition:
India

Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

2.95USD
1:30am IST
Change (% chg)

$0.02 (+0.68%)
Prev Close
$2.93
Open
$2.95
Day's High
$2.96
Day's Low
$2.87
Volume
33,440
Avg. Vol
53,590
52-wk High
$4.35
52-wk Low
$1.25

Latest Key Developments (Source: Significant Developments)

Anavex Life Sciences Q1 Loss Per Share $0.16
Thursday, 7 Feb 2019 

Feb 7 (Reuters) - Anavex Life Sciences Corp ::ANAVEX LIFE SCIENCES REPORTS FISCAL 2019 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CLINICAL STUDY UPDATES.Q1 LOSS PER SHARE $0.16.CASH AND EQUIVALENTS OF $20.7 MILLION AT DECEMBER 31, 2018, COMPARED TO $22.9 MILLION AT SEPTEMBER 30, 2018..  Full Article

Anavex Life Sciences reports PK and PD data from Phase 2a trial of ANAVEX2-73
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - Anavex Life Sciences Corp :Anavex Life Sciences reports PK and PD data from Phase 2a trial of ANAVEX2-73 in mild-to-moderate Alzheimer’s Disease patients.Anavex Life Sciences Corp - ‍ANAVEX2-73 demonstrates desirable PK/PD properties.Anavex Life Sciences Corp - ‍clear concentration-effect relationship between ANAVEX2-73 and study measurements​.  Full Article

Anavex reports Q3 loss per share of $0.09
Monday, 7 Aug 2017 

Aug 7 (Reuters) - Anavex Life Sciences Corp :Anavex reports fiscal third quarter 2017 financial results.Q3 loss per share $0.09.  Full Article

Anavex Life Sciences says selling security holder‍​ to issue 5 mln shares of common stock‍​
Saturday, 27 May 2017 

May 26 (Reuters) - Anavex Life Sciences Corp ::Anavex Life Sciences Corp says selling security holder‍​ to issue 5 million shares of common stock - sec filing ‍​.  Full Article

Anavex Q2 loss per share $0.04
Wednesday, 10 May 2017 

May 10 (Reuters) - Anavex Life Sciences Corp :Anavex reports fiscal second quarter 2017 financial results.Q2 loss per share $0.04.Anavex life sciences corp - cash and equivalents of $23.4 million at march 31, 2017, compared to $9.2 million at september 30, 2016.  Full Article